Neurodegenerative Disease Assay Portfolio

About IBL America

IBL America is a long-standing, privately-held reagent company serving the research and clinical testing markets with a focus on immunoassays. The company's core strength lies in its extensive catalog of validated ELISA and antibody products, especially for the neuroscience sector, where it offers assays for targets like amyloid beta and alpha Klotho. It operates a direct-to-researcher business model, selling high-margin consumable kits to academic, pharmaceutical, and diagnostic laboratories. While not a therapeutic developer, IBL America occupies a stable niche as an essential tools provider in the growing life science research market.

Therapeutic Areas